Penn study shows signs of Alzheimer's disease prevention
A study by Roy Hamilton of the Perelman School of Medicine and colleagues suggests that the drug lecanemab may slow the progression of Alzheimer’s or forestall its effects before they occur.
・ From CBS Philadelphia